HPV Vaccination 'Unmasks' Cervical Lesions From Non-Vax Strains

Clinical trial findings raise concerns amid debate about the future of routine cervical cancer screening.

Related Keywords

Montreal ,Quebec ,Canada ,Maryland ,United States ,Bethesda ,Costa Rica ,Glaxosmith Kline ,Jaimie Shing ,Marc Steben ,National Cancer Institute In Bethesda ,Glaxosmithkline ,National Cancer Institute ,Merck Co ,Office Of Research On Women Health ,University Of Montreal School Public Health ,Published June ,Cervical Cancer ,Alignant Cervix Neoplasm ,Vaccine ,Human Papillomavirus Hpv ,Human Papillomavirus ,Pv ,Clinical Research ,Clinical Trials ,Linical Studies ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Hpv Vaccine ,Human Papillomavirus Vaccine ,Physician Assistants ,Carcinogen ,Fellowship ,Yellows ,Neuroendocrine Tumor ,